Total Payments
$10,967
2024 Payments
$1,787
Companies
14
Transactions
484
Medicare Patients
366
Medicare Billing
$100,765
Payment Breakdown by Category
Food & Beverage$10,950 (99.8%)
Education$16.50 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,950 | 478 | 99.8% |
| Education | $16.50 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $3,034 | 122 | $0 (2024) |
| Alkermes, Inc. | $1,860 | 97 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,612 | 53 | $0 (2024) |
| Lundbeck LLC | $1,394 | 68 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,247 | 60 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $932.12 | 49 | $0 (2020) |
| BioXcel Therapeutics, Inc. | $349.09 | 11 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $343.17 | 15 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $46.07 | 2 | $0 (2024) |
| Indivior Inc. | $39.45 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,787 | 79 | Alkermes, Inc. ($513.05) |
| 2023 | $2,139 | 92 | Alkermes, Inc. ($499.20) |
| 2022 | $1,142 | 55 | Otsuka America Pharmaceutical, Inc. ($376.39) |
| 2021 | $1,186 | 62 | Otsuka America Pharmaceutical, Inc. ($543.26) |
| 2020 | $1,081 | 51 | Otsuka America Pharmaceutical, Inc. ($420.98) |
| 2019 | $1,730 | 72 | Otsuka America Pharmaceutical, Inc. ($581.12) |
| 2018 | $1,569 | 57 | Otsuka America Pharmaceutical, Inc. ($500.37) |
| 2017 | $333.49 | 16 | Lundbeck LLC ($171.38) |
All Payment Transactions
484 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $27.36 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: CNS | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: CNS | ||||||
| 11/21/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $25.51 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: CNS | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $36.75 | General |
| Category: Neuropsychiatry | ||||||
| 11/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: CNS | ||||||
| 11/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Neuropsychiatry | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Neuropsychiatry | ||||||
| 10/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Neuropsychiatry | ||||||
| 10/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: CNS | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: CNS | ||||||
| 10/01/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: Neuroscience | ||||||
| 09/27/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: CNS | ||||||
| 09/25/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 55 | 262 | $61,599 | $18,675 |
| 2022 | 3 | 88 | 474 | $103,377 | $32,324 |
| 2021 | 3 | 75 | 281 | $65,722 | $21,028 |
| 2020 | 5 | 148 | 393 | $89,285 | $28,739 |
Total Patients
366
Total Services
1,410
Medicare Billing
$100,765
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 41 | 247 | $55,817 | $17,001 | 30.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 15 | $5,782 | $1,674 | 29.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 52 | 436 | $91,333 | $28,880 | 31.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 21 | $8,440 | $2,283 | 27.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 15 | 17 | $3,604 | $1,161 | 32.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 120 | $36,368 | $11,596 | 31.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 114 | $24,082 | $7,726 | 32.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 16 | 47 | $5,272 | $1,706 | 32.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 28 | 162 | $50,255 | $15,807 | 31.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 35 | 102 | $21,928 | $6,832 | 31.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 19 | 20 | $6,000 | $2,474 | 41.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 23 | 64 | $7,727 | $2,254 | 29.2% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2020 | 43 | 45 | $3,375 | $1,371 | 40.6% |
About Dr. Amal Saha, M.D
Dr. Amal Saha, M.D is a Psychiatry healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003861220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amal Saha, M.D has received a total of $10,967 in payments from pharmaceutical and medical device companies, with $1,787 received in 2024. These payments were reported across 484 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($10,950).
As a Medicare-enrolled provider, Saha has provided services to 366 Medicare beneficiaries, totaling 1,410 services with total Medicare billing of $100,765. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Brooklyn, NY
- Active Since 05/24/2006
- Last Updated 10/10/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003861220
Products in Payments
- ABILIFY MAINTENA (Drug) $3,350
- INGREZZA (Drug) $1,612
- ARISTADA (Drug) $1,272
- INVEGA SUSTENNA (Drug) $1,225
- LATUDA (Drug) $918.58
- ABILIFY ASIMTUFII (Drug) $627.79
- IGALMI (Drug) $349.09
- REXULTI (Drug) $318.92
- VIVITROL (Drug) $295.87
- Vivitrol (Drug) $179.07
- AUSTEDO (Drug) $134.23
- ABILIFY MYCITE (Drug) $130.98
- UZEDY (Drug) $127.14
- CAPLYTA (Drug) $82.73
- Aristada 441 mg (Drug) $65.62
- LYBALVI (Drug) $47.17
- PERSERIS (Drug) $39.45
- VRAYLAR (Drug) $34.71
- Austedo XR (Drug) $31.69
- Azstarys (Drug) $23.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Brooklyn
Dr. Mark Owens, Do, DO
Psychiatry — Payments: $502,442
Psychiatry $502,442
Dr. Nancy Abdel-Wahab, M.d, M.D
Psychiatry — Payments: $194,999
Psychiatry $194,999
Louis Belzie, Md, Phd, MD, PHD
Psychiatry — Payments: $178,082
Psychiatry $178,082
Alexander Pinkusovich, Md, MD
Psychiatry — Payments: $111,246
Psychiatry $111,246
Dr. Mark Gurtovy, M.d, M.D
Psychiatry — Payments: $31,729
Psychiatry $31,729
Thresiamma Nidhiry, Md, MD
Psychiatry — Payments: $27,833
Psychiatry $27,833